SGLT2 inhibitors act from the extracellular surface of the cell membrane

SGLT2 inhibitors are a new class of drugs that have been recently developed to treat type II diabetes. They lower glucose levels by inhibiting the renal Na(+)/glucose cotransporter SGLT2, thereby increasing the amount of glucose excreted in the urine. Pharmacodynamics studies have raised questions a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghezzi, Chiara, Hirayama, Bruce A., Gorraitz, Edurne, Loo, Donald D. F., Liang, Yin, Wright, Ernest M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208661/
https://www.ncbi.nlm.nih.gov/pubmed/24973332
http://dx.doi.org/10.14814/phy2.12058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208661/
https://www.ncbi.nlm.nih.gov/pubmed/24973332
http://dx.doi.org/10.14814/phy2.12058

Ejemplares similares